Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of conjugated estrogen cream to improve colposcopy quality in postmenopausal women
CTR20261289Phase 3Active
- Sponsor
- Xinjiang Xinziyuan Biopharmaceutical
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vaginal atrophy and None comparing Conjugated estrogens vaginal cream with Placebo cream (2 arms). Primary endpoint: Complete cervical exposure rate after 14 days of treatment during colposcopy. Started May 2026; status: active.
02
Drugs
conjugated estrogens
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on CTR20261289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261289.